Search Medical Condition
Please enter condition
Please choose location
 

Linyi, China Clinical Trials

A listing of Linyi, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (7) clinical trials

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.

Phase

0.0 miles

Learn More »

Aromasin Non-Interventional Study Of Early Invasive Breast Cancer Patients In China

This is non-interventional study and single arm study. N/A

Phase

0.0 miles

Learn More »

Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome

The purpose of this study is to evaluate the clinical effectiveness of PINS vagus nerve stimulatior in children with Lennox-Gastaut Syndrome.

Phase N/A

2.26 miles

Learn More »

Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation

Primary objective of the trial is to evaluate the safety of afatinib in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR (Epidermal growth factor receptor) mutation(s) and have never been treated with an EGFR-TKI (tyrosine kinase inhibitor). Secondary objective is to assess the time to ...

Phase

2.63 miles

Learn More »

A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

This is a randomized, double-blind, placebo-controlled, multi-center Phase III clinical trial in patients with advanced non-squamous non-small cell lung cancer (NSCLC) treated with Fruquintinib who failed 2 lines of systemic chemotherapy or with non-tolerable toxicities. Approximately 521 subjects will be randomized to Fruquintinib group or placebo group at a ratio ...

Phase

3.69 miles

Learn More »

Study of Methylnaltrexone in Opioid-Induced Constipation Patients

Methylnaltrexone is a quaternary derivative of the pure opioid antagonists naltrexone. It is fairly lipid soluble and readily cross the blood-brain barrier. This property provides methylnaltrexone with the potential to block the undesired side-effects of opioid pain medications predominantly mediated by receptors located peripherally while sparing opioid effects mediated at ...

Phase

6.69 miles

Learn More »

Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)

To compare the effects and safety of Anlotinib with placebo in patients with small cell lung cancer(SCLC).

Phase

6.69 miles

Learn More »